Monte Rosa Therapeutics, Inc. (GLUE) reported Q1 Revenue

Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) reported Q1 Revenue for the quarter came in at $84.93 million versus the consensus estimate of $4.91 million.

For earnings history and earnings-related data on Monte Rosa Therapeutics, Inc. (GLUE) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Berkshire adds significantly to Alphabet position, starts small position in DR Horton
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c